Correction to: Assessing the clinical utility of pre-operative neutrophil–lymphocyte ratio as a predictor of clinicopathological parameters in patients being treated for primary breast cancer (Breast Cancer Research and Treatment, (2025), 210, 3, (783-790), 10.1007/s10549-025-07615-8)

Research output: Contribution to journalComment/debate

Abstract

In this article, James A.L. Brown at affiliations ‘Department of Biological Sciences, University of Limerick, Galway, Ireland’ and ‘Limerick Digital Cancer Research Centre (LDCRC), University of Limerick, Limerick, Ireland’ was missing from the author list. The original article has been corrected.

Original languageEnglish
Pages (from-to)759
Number of pages1
JournalBreast Cancer Research and Treatment
Volume211
Issue number3
DOIs
Publication statusPublished - Jun 2025

Fingerprint

Dive into the research topics of 'Correction to: Assessing the clinical utility of pre-operative neutrophil–lymphocyte ratio as a predictor of clinicopathological parameters in patients being treated for primary breast cancer (Breast Cancer Research and Treatment, (2025), 210, 3, (783-790), 10.1007/s10549-025-07615-8)'. Together they form a unique fingerprint.

Cite this